{"id":"W4409956934","doi":"10.1002/cpdd.1538","title":"A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare","keywords":"Medicine; Tolerability; Dosing; Pharmacokinetics; Adverse effect; Pharmacology; Regimen; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002341924,0.00150551,0.002075747,0.0003051551,0.0004558825,0.0008219206,0.0007911726,0.001451512,0.00560956],"category_scores_gemma":[0.002523375,0.0008583185,0.001078485,0.0003538867,0.0009167394,0.0009659777,0.0003235281,0.00228291,0.0007189377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006946437,"about_ca_system_score_gemma":0.001798753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007019071,"about_ca_topic_score_gemma":0.002016201,"domain_scores_codex":[0.9991352,0.0004969563,0.00004183781,0.0001582287,0.00007406285,0.00009376065],"domain_scores_gemma":[0.9986746,0.0004608831,0.0003113644,0.0001038675,0.0001162187,0.0003331462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9571148,0.02253399,0.000942263,0.0004212353,0.0005811101,0.00005343845,0.00006699636,0.000338323,0.005290571,0.0001009631,0.0007977017,0.01175861],"study_design_scores_gemma":[0.7964044,0.1989731,0.002011547,0.00002223454,0.0003648726,0.00004791483,0.00002369758,0.0005912411,0.0006332565,0.0001343382,0.0007781964,0.00001523511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837399,0.001773762,0.001200252,0.0003276822,0.0002844483,0.009929835,0.001190002,0.0001007276,0.001453366],"genre_scores_gemma":[0.9789257,0.001705302,0.003186467,0.0009567162,0.0002994389,0.01094029,0.001225028,0.00003932934,0.002721686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00560956,"threshold_uncertainty_score":0.01876587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0388030569631078,"score_gpt":0.4428926940845356,"score_spread":0.4040896371214278,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}